BusinessaTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate UpdateBy Nasdaq OMXMar 19, 2018, 8:05 PM UTC
BusinessaTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumBy Nasdaq OMXDec 21, 2017, 1:01 PM UTC
BusinessVBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017By Nasdaq OMXNov 10, 2017, 1:00 PM UTC
BusinessNew Study Demonstrates Anti-Tumor Advantages for Combination Treatment Featuring Peregrine Pharmaceuticals’ PS-Targeting Antibodies in a Preclinical Melanoma ModelBy Nasdaq OMXNov 14, 2016, 1:05 PM UTC
BusinessNew XOMA Antibodies Unveiled at The Society for Immunotherapy of Cancer 31st Annual MeetingBy Nasdaq OMXNov 8, 2016, 2:01 PM UTC
BusinessNew XOMA Antibodies Unveiled at The Society for Immunotherapy of Cancer 31st Annual MeetingBy Nasdaq OMXNov 8, 2016, 2:01 PM UTC
